David Beckham-Backed Prenetics Ditches Bitcoin Purchase

Why It Matters

The move highlights growing corporate caution toward crypto treasuries and reinforces the priority of sustainable, core‑business growth for shareholder value. It also signals to other firms that volatile digital assets may no longer justify balance‑sheet allocation.

Key Takeaways

• Prenetics stops new Bitcoin purchases, keeps 510 BTC
• IM8 supplements produce $100M+ annual recurring revenue
• $48M funding initially earmarked for crypto now redirected
• Crypto market weakness drives corporate treasury strategy shift
• David Beckham-backed firm prioritizes core health business

Pulse Analysis

Corporate crypto treasuries surged in early 2024 as firms chased the Michael Saylor playbook, raising capital to buy and hold Bitcoin as a hedge and a potential upside driver. Prenetics joined that wave in June, leveraging a $48 million round that included crypto‑focused investors such as Kraken and Exodus. However, the sharp correction in Bitcoin’s price after October eroded the perceived upside, prompting board members to reassess the risk‑return profile of a balance‑sheet exposure that now appears more speculative than strategic.

At the same time, Prenetics’ IM8 supplement platform has exceeded growth expectations, delivering over $100 million in annualized recurring revenue within its first year. The health‑tech market continues to reward products that combine personalized nutrition with data‑driven insights, and IM8’s rapid scaling aligns with consumer demand for wellness solutions backed by scientific validation. By reallocating the $48 million funding toward product development, global distribution, and marketing, Prenetics aims to cement its position in a high‑margin segment, generating predictable cash flow that can sustain long‑term shareholder returns.

The broader implication for the industry is a recalibration of crypto‑centric treasury strategies. Investors are now scrutinizing the tangible benefits of digital‑asset holdings versus the volatility they introduce to balance sheets. Companies like Prenetics illustrate that when core business performance outpaces speculative gains, the prudent path is to double down on proven revenue engines. This shift may temper the enthusiasm for corporate Bitcoin accumulation, encouraging firms to adopt more balanced capital allocation frameworks that prioritize operational excellence and measurable growth.